Rockwell Medical PE Ratio 2010-2023 | RMTI
Current and historical p/e ratio for Rockwell Medical (RMTI) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Rockwell Medical PE ratio as of April 15, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Rockwell Medical PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-04-15 | 1.53 | 0.00 | |
| 2023-09-30 | 2.08 | $-0.55 | 0.00 |
| 2023-06-30 | 5.46 | $-0.88 | 0.00 |
| 2023-03-31 | 1.81 | $-1.26 | 0.00 |
| 2022-12-31 | 1.02 | $-2.00 | 0.00 |
| 2022-09-30 | 1.32 | $-1.80 | 0.00 |
| 2022-06-30 | 1.29 | $-2.28 | 0.00 |
| 2022-03-31 | 5.18 | $-2.71 | 0.00 |
| 2021-12-31 | 4.51 | $-2.75 | 0.00 |
| 2021-09-30 | 6.56 | $-3.74 | 0.00 |
| 2021-06-30 | 10.01 | $-3.96 | 0.00 |
| 2021-03-31 | 12.76 | $-4.07 | 0.00 |
| 2020-12-31 | 11.11 | $-4.51 | 0.00 |
| 2020-09-30 | 11.77 | $-4.73 | 0.00 |
| 2020-06-30 | 21.45 | $-4.95 | 0.00 |
| 2020-03-31 | 22.55 | $-5.83 | 0.00 |
| 2019-12-31 | 26.84 | $-6.16 | 0.00 |
| 2019-09-30 | 30.36 | $-6.82 | 0.00 |
| 2019-06-30 | 33.11 | $-6.60 | 0.00 |
| 2019-03-31 | 62.59 | $-7.26 | 0.00 |
| 2018-12-31 | 24.86 | $-7.04 | 0.00 |
| 2018-09-30 | 46.42 | $-7.15 | 0.00 |
| 2018-06-30 | 54.23 | $-7.15 | 0.00 |
| 2018-03-31 | 57.31 | $-6.05 | 0.00 |
| 2017-12-31 | 64.02 | $-5.61 | 0.00 |
| 2017-09-30 | 94.16 | $-4.73 | 0.00 |
| 2017-06-30 | 87.23 | $-4.62 | 0.00 |
| 2017-03-31 | 68.86 | $-4.29 | 0.00 |
| 2016-12-31 | 72.05 | $-4.40 | 0.00 |
| 2016-09-30 | 73.70 | $-4.62 | 0.00 |
| 2016-06-30 | 83.27 | $-4.18 | 0.00 |
| 2016-03-31 | 82.61 | $-3.52 | 0.00 |
| 2015-12-31 | 112.64 | $-3.19 | 0.00 |
| 2015-09-30 | 84.81 | $-3.41 | 0.00 |
| 2015-06-30 | 177.32 | $-3.96 | 0.00 |
| 2015-03-31 | 120.23 | $-4.29 | 0.00 |
| 2014-12-31 | 113.08 | $-5.72 | 0.00 |
| 2014-09-30 | 100.54 | $-6.49 | 0.00 |
| 2014-06-30 | 131.89 | $-9.13 | 0.00 |
| 2014-03-31 | 139.26 | $-12.43 | 0.00 |
| 2013-12-31 | 114.84 | $-18.15 | 0.00 |
| 2013-09-30 | 125.41 | $-23.10 | 0.00 |
| 2013-06-30 | 39.71 | $-28.82 | 0.00 |
| 2013-03-31 | 43.56 | $-31.02 | 0.00 |
| 2012-12-31 | 88.55 | $-29.04 | 0.00 |
| 2012-09-30 | 89.87 | $-27.17 | 0.00 |
| 2012-06-30 | 102.41 | $-20.79 | 0.00 |
| 2012-03-31 | 104.06 | $-17.27 | 0.00 |
| 2011-12-31 | 93.17 | $-13.20 | 0.00 |
| 2011-09-30 | 89.76 | $-8.91 | 0.00 |
| 2011-06-30 | 141.24 | $-6.27 | 0.00 |
| 2011-03-31 | 98.79 | $-3.30 | 0.00 |
| 2010-12-31 | 86.90 | $-1.65 | 0.00 |
| 2010-09-30 | 77.88 | $-0.88 | 0.00 |
| 2010-06-30 | 58.85 | $-1.65 | 0.00 |
| 2010-03-31 | 63.58 | $-3.08 | 0.00 |
| 2009-12-31 | 84.59 | $-4.18 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.047B | $0.084B |
| Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrates and dialysis kits, and sells, distributes and delivers such concentrates and dialysis kits, as well as other ancillary hemodialysis products, to hemodialysis providers in the United States. Hemodialysis is a process which is able to duplicate kidney function in patients whose kidneys have failed to function properly. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $189.326B | 24.57 |
| Stryker (SYK) | United States | $130.140B | 32.27 |
| Medtronic (MDT) | Ireland | $106.398B | 15.06 |
| Boston Scientific (BSX) | United States | $99.865B | 33.21 |
| EssilorLuxottica (ESLOY) | France | $97.453B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.386B | 0.00 |
| Haleon (HLN) | United Kingdom | $36.575B | 28.61 |
| ResMed (RMD) | United States | $27.338B | 27.33 |
| Zimmer Biomet Holdings (ZBH) | United States | $25.576B | 16.47 |
| Terumo (TRUMY) | Japan | $24.984B | 35.28 |
| Baxter (BAX) | United States | $20.481B | 14.94 |
| Koninklijke Philips (PHG) | Netherlands | $18.629B | 14.86 |
| Insulet (PODD) | United States | $12.269B | 64.42 |
| Demant (WILYY) | Denmark | $10.561B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.391B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.568B | 25.53 |
| BellRing Brands (BRBR) | United States | $7.201B | 38.72 |
| Haemonetics (HAE) | United States | $4.328B | 22.14 |
| Lantheus Holdings (LNTH) | United States | $4.167B | 10.76 |
| Perrigo (PRGO) | Ireland | $4.109B | 11.75 |
| GN Store Nord (GNNDY) | Denmark | $3.721B | 24.09 |
| Prestige Consumer Healthcare (PBH) | United States | $3.388B | 16.02 |
| Envista Holdings (NVST) | United States | $3.296B | 12.54 |
| QuidelOrtho (QDEL) | United States | $2.820B | 10.23 |
| Green Thumb Industries (GTBIF) | United States | $2.682B | 85.00 |
| Neogen (NEOG) | United States | $2.682B | 25.79 |
| ICU Medical (ICUI) | United States | $2.393B | 17.85 |
| TG Therapeutics (TGTX) | United States | $2.187B | 708.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.112B | 0.00 |
| Owens & Minor (OMI) | United States | $1.959B | 18.81 |
| Verano Holdings (VRNOF) | United States | $1.745B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.658B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.529B | 47.61 |
| InMode (INMD) | Israel | $1.505B | 7.79 |
| LeMaitre Vascular (LMAT) | United States | $1.442B | 47.89 |
| AdaptHealth (AHCO) | United States | $1.308B | 9.84 |
| Warby Parker (WRBY) | United States | $1.301B | 0.00 |
| AtriCure (ATRC) | United States | $1.165B | 0.00 |
| MacroGenics (MGNX) | United States | $1.097B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.747B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.711B | 0.00 |
| Evolus (EOLS) | United States | $0.701B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.700B | 15.13 |
| Quanterix (QTRX) | United States | $0.699B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.691B | 0.00 |
| Valneva SE (VALN) | France | $0.591B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.531B | 11.50 |
| TerrAscend (TSNDF) | Canada | $0.524B | 0.00 |
| PetIQ (PETQ) | United States | $0.484B | 18.09 |
| Jin Medical (ZJYL) | China | $0.481B | 0.00 |
| Biote (BTMD) | United States | $0.449B | 4.27 |
| ZimVie (ZIMV) | United States | $0.433B | 26.50 |
| OraSure Technologies (OSUR) | United States | $0.422B | 6.99 |
| Surmodics (SRDX) | United States | $0.384B | 41.54 |
| Zynex (ZYXI) | United States | $0.383B | 44.11 |
| Aurora Cannabis (ACB) | Canada | $0.360B | 0.00 |
| Cerus (CERS) | United States | $0.317B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.317B | 31.46 |
| Sanara MedTech (SMTI) | United States | $0.289B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.248B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.246B | 15.02 |
| Veru (VERU) | United States | $0.223B | 0.00 |
| Omeros (OMER) | United States | $0.218B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.200B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.197B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.186B | 0.00 |
| High Tide (HITI) | Canada | $0.179B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.163B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.131B | 66.00 |
| FitLife Brands (FTLF) | United States | $0.130B | 20.89 |
| Jushi Holdings (JUSHF) | United States | $0.120B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.113B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.112B | 0.00 |
| Fonar (FONR) | United States | $0.109B | 9.33 |
| InterCure (INCR) | Israel | $0.108B | 18.15 |
| Safety Shot (SHOT) | United States | $0.106B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.102B | 0.00 |
| MariMed (MRMD) | United States | $0.096B | 0.00 |
| Chimerix (CMRX) | United States | $0.086B | 0.00 |
| Brainsway (BWAY) | Israel | $0.086B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.074B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.89 |
| Apyx Medical (APYX) | United States | $0.051B | 0.00 |
| United Health Products (UEEC) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Bright Green (BGXX) | United States | $0.043B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.035B | 13.66 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.026B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.021B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 71.82 |
| ProSomnus (OSA) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |